Product image of Willfact (Human Von Willebrand Factor) supplied by GNH India

Willfact

Active Ingredient:
Human Von Willebrand Factor
Origin:
EU

Willfact (Human Von Willebrand Factor)

Willfact is a human von Willebrand factor concentrate used to manage bleeding disorders like von Willebrand disease. This intravenous therapy helps restore normal clotting function. Suitable for patients requiring factor replacement during procedures or acute bleeding episodes. A trusted option for inherited bleeding disorder management.

Manufacturer / TM Owner

Lfb Biomedicaments

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Human von Willebrand factor is prescribed to treat and prevent bleeding in patients with von Willebrand disease, a condition where blood doesn’t clot properly. It may also be used before surgeries or dental procedures to reduce bleeding risk. This therapy replaces missing or dysfunctional clotting proteins, supporting normal blood coagulation. Often used for acute bleeding episodes or routine prophylaxis.

Side Effects

  • After administration, von Willebrand factor concentrates help restore clotting ability, reducing prolonged bleeding times. Patients may experience improved bleeding control within hours of infusion. Some report reduced bruising or spontaneous bleeding episodes with regular use. Effects vary based on individual response and condition severity.

Precautions & Warnings

  • Store Willfact as directed, typically refrigerated but not frozen, and use within the specified shelf life. Always check the product for particles or discoloration before use. Administer under medical supervision to monitor for infusion reactions. Keep emergency contact information accessible during treatment.

Avoid Interactions

  • Avoid mixing with other medications in the same IV line unless approved by a healthcare provider. Certain medications, such as antifibrinolytics or hormonal therapies, may interact with clotting factors—consult a doctor before combining treatments. Alcohol and some herbal supplements can affect blood clotting and should be used cautiously.

Frequently Asked Questions

Willfact is used to treat and prevent bleeding in patients with von Willebrand disease.

Willfact is given as an intravenous infusion under medical supervision.

Use during pregnancy should be discussed with a healthcare provider to assess benefits and risks.

Possible side effects include headache, nausea, or infusion site reactions.

Safety and dosing in children should be determined by a pediatric specialist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT